Search results for " DRUG DELIVERY"

showing 10 items of 195 documents

Liposomes as nonspecific nanocarriers for 5-Fluorouracil in the presence of cyclodextrins

2021

Abstract 5-Fluorouracil (5-FU) is one of anticancer drugs with broad activity. Due to its severe side effects, recent studies concentrate on new ways of directed 5-FU delivery and its release in ill tissue. One of selective carriers could be cyclodextrins and liposomes. The combination of novel methods, leading to formation of inclusion complexes (IC) between host molecule of β-cyclodextrin (β-CD) or 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) and 5-FU guest and its subsequent encapsulation in dipalmitoylphosphatidylcholine (DPPC) liposomes is studied experimentally in the present work. Several methods are applied to proof the encapsulation of the analysed drug and its release over time at 37 …

Release mechanismLiposomeCyclodextrins5-Fluorouraciltechnology industry and agricultureCondensed Matter PhysicsCombinatorial chemistryAtomic and Molecular Physics and OpticsFluorescence spectroscopyElectronic Optical and Magnetic MaterialsNMR spectra databasechemistry.chemical_compoundDifferential scanning calorimetrychemistryDipalmitoylphosphatidylcholineLiposomesMaterials ChemistryProton NMRMoleculelipids (amino acids peptides and proteins)Physical and Theoretical ChemistryNanocarriersSpectroscopyControlled drug deliveryJournal of Molecular Liquids
researchProduct

2014

In the pathogenesis of Alzheimer’s disease (AD) the homeostasis of amyloid precursor protein (APP) processing in the brain is impaired. The expression of the competing proteases ADAM10 (a disintegrin and metalloproteinase 10) and BACE-1 (beta site APP cleaving enzyme 1) is shifted in favor of the A-beta generating enzyme BACE-1. Acitretin–a synthetic retinoid–e.g., has been shown to increase ADAM10 gene expression, resulting in a decreased level of A-beta peptides within the brain of AD model mice and thus is of possible value for AD therapy. A striking challenge in evaluating novel therapeutically applicable drugs is the analysis of their potential to overcome the blood-brain barrier (BBB)…

Reporter geneMultidisciplinarybiologyADAM10TransfectionPharmacologyBlood–brain barriermedicine.anatomical_structureBeta-secretase 1Targeted drug deliverymedicinebiology.proteinAmyloid precursor proteinAmyloid precursor protein secretasePLOS ONE
researchProduct

Cholesterol-Inulin Conjugates for Efficient SN38 Nuclear Delivery: Nanomedicines for Precision Cancer Therapy

2022

An amphiphilic inulin-thiocholesterol conjugate (INU-Cys-TC) was strategically designed as a biodegradable core-shell nanocarrier of 7-ethyl-10-hydroxy-camptothecin (SN38) to enhance its solubility and stability in aqueous media, thus exploiting its brilliant anticancer effect. INU-Cys-TC was designed to have the hydrophilic inulin backbone (external shell) partially functionalized with hydrophobic thiocholesterol moieties (internal core) through a biodegradable disulfide bond due to cysteamine bridges. Thiocholesterol moieties impair redox-sensitive self-assembling abilities, yielding to nano-sized micelles in aqueous media capable of efficiently encapsulating a high amount of SN38 (DL = 8…

SN38Cancer ResearchinulinOncologytriple negative breast cancerdrug deliverycolorectal cancerpolymeric micellesinulin; SN38; drug delivery; polymeric micelles; colorectal cancer; triple negative breast cancerCancers; Volume 14; Issue 19; Pages: 4857
researchProduct

Retinal neurodegeneration and an innovative nanostructured approach in an iron overload in vivo model

2020

Settore BIO/16 - Anatomia UmanaRETINA RETINAL DEGENERATION IRON DRUG DELIVERY.Settore BIO/09 - Fisiologia
researchProduct

CURCUMIN-LOADED LIPID NANOSTRUCTURES AS DRUG DELIVERY SYSTEMS.

2009

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoCURCUMIN LIPID NANOSTRUCTURES DRUG DELIVERY SYSTEMS.
researchProduct

Casein-loaded proteoliposomes: Drug Delivery Systems and Potential Inhibitors in Aβ1-40 Fibrillogenesis

2018

Alzheimer's disease (AD) represents the most common cause of dementia worldwide. The early symptom is usually a short-term memory loss, followed by symptoms including problems with language, disorientation, mood swings, loss of motivation, not managing self-care, and behavioral issues, until loss of body functions and, ultimately, death. The cause of AD is poorly understood and the diagnosis is complex. One of the main AD hallmarks is the extracellular deposition in brain tissue of proteinaceous amyloid plaques, composed by well-ordered fibrillary aggregates of the amyloid β-peptide (Aβ). The Aβ aggregation process follows typical nucleation-polymerization kinetics, characterized by structu…

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoCaseina Drug Delivery Liposomes Fibrillogenesis Alzheimer's
researchProduct

FOLATE-MEDIATED TARGETING OF POLYMERS AS COMPONENTS OF COLLOIDAL DRUG DELIVERY SYSTEMS

2009

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoFolate polymers colloidal drug delivery system
researchProduct

Development of nimesulide loaded solid lipid nanoparticles.

2009

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoSOLID LIPID NANOPARTICLES DRUG DELIVERY
researchProduct

Sviluppo di spugne bioerodibili multifunzionali per la promozione di processi riparativi mediante il rilascio controllato di agenti antibiotici e ant…

2023

La salute delle strutture molli e dure del cavo orale è essenziale non solo per preservare le funzioni ad esse direttamente associate, ma anche per promuovere la salute generale dell’organismo. Tra le problematiche di maggiore interesse clinico a carico della cavità orale ritroviamo: i) le complicazioni post-operatorie che possono verificarsi a seguito di comuni avulsioni dentali che, se non trattate tempestivamente, possono sfociare in gravi parodontiti; ii) i fenomeni di osteonecrosi a carico di mascella e mandibola associate a trattamenti farmacologici nonché alla radioterapia; iii) il carcinoma orale a cellule squamose (OSCC) che è tra i più aggressivi tumori del collo e della testa, ca…

Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoSettore MED/28 - Malattie Odontostomatologicheoral disease polyphenols drug delivery system nanostructured lipid carrier nanocomposite polymeric microparticle spray drying 3D-printed scaffold wound healing controlled drug release kinetic evaluation.
researchProduct

POLYMERIC MICELLES BASED ON A PHOSPHOLIPID/ POLYASPARTAMIDIC COPOLYMER FOR BECLOMETHASONE DIPROPIONATE DELIVERY TO THE LUNGS

2010

Settore CHIM/09 - Farmaceutico Tecnologico Applicativoalphabeta-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA) 12-Distearoyl-sn-glycero-3-Phosphoethanolamine-N-[Amino(Polyethylene glycol)2000] (DSPE-PEG2000-NH2) polymeric micelles drug delivery beclomethasone dipropionate (BDP) pulmonary diseases.
researchProduct